Bandingkan Harga & Kinerja Itama Ranoraya Tbk (IRRA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Itama Ranoraya Tbk dan Organon Pharma Indonesia Tbk.: Itama Ranoraya Tbk diperdagangkan di Rp374 (kapitalisasi pasar 598,4 M, volume 24 jam 375,6 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Itama Ranoraya Tbk jauh lebih besar — sekitar 5,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IRRA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 598,4 M | 104,4 M |
Volume | 375,6 rb | — |
Lot | 3,76 rb | — |
Perputaran | 139,49 jt | — |
Harga Rata-rata | 371,39 | — |
Nilai Transaksi | 139,49 jt | — |
Harga Ekuilibrium Indikatif | 374 | — |
Volume Ekuilibrium Indikatif | 480 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Itama Ranoraya Tbk
PT. Itama Ranoraya Tbk ( theEntity) was established for the first time based on Deed of Establishment of Limited Liability Entity dated November 30, 1989 Number 116, made before Esther Daniar Iskandar, S.H., Notary in Jakarta. PT Global Dinamika Kencana is the majority shareholder of the Entity and also the Ultimate Parent Entity. The entity has started commercial operations at July 22, 2002.
Selengkapnya di halaman IRRA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
